Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study "XASSURE"


Phase Results N/A

Summary of Purpose

This non-interventional field study will investigate rivaroxaban under clinical practice conditions for stroke prevention and for prevention of non-CNS systemic embolism in patients with non-valvular atrial fibrillation in China.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 May 2018.

11 May 2016 27 Apr 2016 30 Jun 2021 30 Aug 2021 1 May 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Non-Probability Sample